Risperidone Long-Acting Injectable (Lai) Suspension Suppliers & Bulk Manufacturers
Available Forms: Long-acting injectable (LAI) suspension
Available Strengths: 25 mg, 37.5 mg, 50 mg per dose
Reference Brands: Risperdal®(US & EU); EU: Risperidon-ratiopharm®, Rispolept®, Rispen®
Category: Antipsychotropic Drugs
Risperidone long-acting injection is an antipsychotic given every two weeks or monthly for schizophrenia and bipolar disorder, so patients do not need daily tablets. The original product, Risperdal Consta (25 to 50 mg microspheres), needs cold-chain storage at 2–8 °C. Newer monthly forms are given under the skin. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.
Manufacture or export Risperidone Long-Acting Injectable (Lai) Suspension? List it or send an offer →
Product Description:
Risperidone Long-Acting Injectable (LAI) suspension is approved by the FDA in the United States and the EMA in the European Union for the treatment of schizophrenia and maintenance therapy in bipolar I disorder. It offers an extended-release formulation designed for intramuscular injection every two weeks or monthly, ensuring steady therapeutic levels and improving medication adherence. Regulatory bodies emphasize its importance in reducing relapse rates and hospitalizations. Prescribers must adhere to initiation protocols, especially when transitioning from oral risperidone. To explore additional forms and strengths of risperidone LAI, visit Pharmatradz.com.
Risperidone Long-Acting Injectable (Lai) Suspension — third party manufacturing & bulk supply
Risperidone Long-Acting Injectable (Lai) Suspension is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Risperidone Long-Acting Injectable (Lai) Suspension is supplied as Long-acting injectable (LAI) suspension — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Risperidone Long-Acting Injectable (Lai) Suspension listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Risperidone Long-Acting Injectable (Lai)... →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Risperidone injection is used for the treatment of schizophrenia and sometimes bipolar disorder. Long-acting formulations are given to patients who need consistent antipsychotic treatment and may have difficulty taking daily oral medication. It helps control symptoms such as hallucinations, delusions, mood changes, and disorganized thinking.
Risperidone injection is made from the active pharmaceutical ingredient risperidone, an atypical antipsychotic compound that works by affecting dopamine and serotonin receptors in the brain. Long-acting injectable versions use specialized delivery systems that release the medicine slowly over time.
The main trade names include Risperdal Consta, Perseris, Uzedy, and Rykindo, along with several regional brand names depending on the country and manufacturer.
Risperdal Consta is manufactured by Janssen Pharmaceuticals (a Johnson & Johnson company). Perseris is produced by Indivior. Uzedy is developed by Teva Pharmaceuticals in collaboration with Medincell. Rykindo is produced by Luye Pharma Group. In India and other markets, various pharmaceutical manufacturers produce risperidone long-acting injections under licensed or local brands.
The generic name is risperidone.
Major brand names include Risperdal Consta, Perseris, Uzedy, and Rykindo.
Risperidone injections are manufactured in multiple countries depending on the brand, including the United States, European Union countries, China, and India, under approved pharmaceutical manufacturing facilities that comply with regulatory standards such as US FDA, EMA, and other national authorities.
The microspheres in Risperdal Consta must be stored at 2–8 °C; they can be kept at room temperature for up to seven days before use.
Risperdal Consta (intramuscular every two weeks), Perseris and Uzedy (monthly or two-monthly under the skin), and Rykindo. Each has its own dosing schedule.
Generic versions are limited because the microsphere technology is complex; registration needs a full complex-generic dossier, so we confirm what is approved for your market.
Related Products
Risperidone Oral Solution
Strength:
1 mg/mL
Form: Oral solution
Reference Brands: Risperdal® (EU & US)
View DetailsRisperidone Tablets
Strength:
0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg
Form: Tablets
Reference Brands: Risperdal®(US & EU); EU: Risperidon-ratiopharm®, Rispolept®, Rispen® '
View DetailsProchlorperazine Maleate Tablet
Strength:
5 mg, 10 mg
Form: Tablet
Reference Brands: US: Compazine®, Procomp®; EU: Stemetil®, Buccastem®
View DetailsProchlorperazine Maleate Buccal Tablets
Strength:
3 mg
Form: Buccal tablets
Reference Brands: US: Compazine®, Procomp®; EU: Stemetil®, Buccastem®
View DetailsHaloperidol Injection
Strength:
5 mg/mL
Form: Injection (IM/IV)
Reference Brands: Haldol®(US)
View DetailsHaloperidol Oral Solution
Strength:
2 mg/mL
Form: Oral Solution
Reference Brands: Haldol(US)
View DetailsChlorpromazine Tablets
Strength:
10 mg, 25 mg, 50 mg, 100 mg, 200 mg
Form: Oral Tablets
Reference Brands: Thorazine®(US); Largactil®(EU)
View DetailsChlorpromazine Syrup
Strength:
30 mg/mL
Form: Oral Syrup
Reference Brands: Largactil® (EU); Thorazine®(US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit